Literature DB >> 9153517

The quest for unbiased research: randomized clinical trials and the CONSORT reporting guidelines.

K F Schulz1.   

Abstract

Mesh：

Year:  1997        PMID： 9153517     DOI： 10.1002/ana.410410504

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  8 in total

1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors:  David Moher; Kenneth F Schulz; Douglas G Altman
Journal:  Clin Oral Investig       Date:  2003-01-31       Impact factor: 3.573

2.  Clinical trials in orthopaedics research. Part III. Overcoming operational challenges in the design and conduct of randomized clinical trials in orthopaedic surgery.

Authors:  Elena Losina; James Wright; Jeffrey N Katz
Journal:  J Bone Joint Surg Am       Date:  2012-03-21       Impact factor: 5.284

Review 3.  [CONSORT statement. Revised findings on quality improvement based on reports from randomized studies in parallel design].

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Schmerz       Date:  2005-04       Impact factor: 1.107

Review 4.  OARSI Clinical Trials Recommendations: Key analytic considerations in design, analysis, and reporting of randomized controlled trials in osteoarthritis.

Authors:  E Losina; J Ranstam; J E Collins; T J Schnitzer; J N Katz
Journal:  Osteoarthritis Cartilage       Date:  2015-05       Impact factor: 6.576

5.  The treatment of multiple sclerosis with inosine.

Authors:  Clyde E Markowitz; Sergei Spitsin; Vanessa Zimmerman; Dina Jacobs; Jayaram K Udupa; D Craig Hooper; Hilary Koprowski
Journal:  J Altern Complement Med       Date:  2009-06       Impact factor: 2.579

6.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  BMC Med Res Methodol       Date:  2001-04-20       Impact factor: 4.615

Review 7.  Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue: Critical Appraisal and Suggestions for Harmonization-A Joint Initiative.

Authors:  Philippe Robert; Thomas Frenzel; Cécile Factor; Gregor Jost; Marlène Rasschaert; Gunnar Schuetz; Nathalie Fretellier; Janina Boyken; Jean-Marc Idée; Hubertus Pietsch
Journal:  Invest Radiol       Date:  2018-09       Impact factor: 6.016

8.  Disbiome database: linking the microbiome to disease.

Authors:  Yorick Janssens; Joachim Nielandt; Antoon Bronselaer; Nathan Debunne; Frederick Verbeke; Evelien Wynendaele; Filip Van Immerseel; Yves-Paul Vandewynckel; Guy De Tré; Bart De Spiegeleer
Journal:  BMC Microbiol       Date:  2018-06-04       Impact factor: 3.605
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.